short bowel syndrome

Ironwood Pharmaceuticals Provides Clinical and Regulatory Update on Apraglutide
Drugs.com
Mon, 04/14/25 - 07:12 pm
Ironwood Pharmaceuticals
short bowel syndrome
clinical trials
apraglutide
FDA rejects Zealand Pharma's GLP-2 analog in rare bowel disease
Fierce Biotech
Thu, 12/19/24 - 09:29 pm
Zealand Pharma
glepaglutide
FDA
short bowel syndrome
Pipeline moves: Approval prospects for SBS candidate rise after Phase III trial meets endpoints
Clinical Trials Arena
Mon, 03/18/24 - 11:09 am
Ironwood Pharmaceuticals
short bowel syndrome
clinical trials
apraglutide
Ironwood's bowel disease treatment meets main goal in late-stage trial
Reuters
Thu, 02/29/24 - 11:02 am
Ironwood
chronic intestinal failure
clinical trials
short bowel syndrome
apraglutide
Zealand Pharma reports data from Phase III short bowel syndrome trial
Clinical Trials Arena
Mon, 10/3/22 - 10:03 am
Zealand Pharma
clinical trials
glepaglutide
short bowel syndrome
Key data catalysts for the industry’s small players
EP Vantage
Fri, 07/1/22 - 09:35 am
Intercept Pharma
Akero
NASH
Kymera
atopic dermatitis
Zealand Pharma
short bowel syndrome
Relmada
Verona
Anavex
Assembly Biosciences
Aldeyra
FDA approves GATTEX for children with short bowel syndrome
Pharmaceutical Business Review
Mon, 05/20/19 - 10:13 am
Takeda
FDA
Gattex
short bowel syndrome
pediatrics
Zealand Pharma blueprints an $86M IPO on Nasdaq as it maneuvers its way into PhIII
Endpoints
Sun, 07/9/17 - 11:33 am
Zealand Pharma
IPO
NASDAQ
dasiglucagon
hypoglycemia
glepaglutide
short bowel syndrome
NPS Pharma Finds Big Success In Tiny Markets
Investors.com
Fri, 02/14/14 - 12:00 pm
NPS Pharmaceuticals
Gattex
short bowel syndrome
Natpara
hypoparathyroidism
NPS Pharma Commences Study on Pediatrics
Yahoo/Zacks.com
Fri, 01/3/14 - 11:50 am
pediatrics
NPS Pharmaceuticals
Gattex
short bowel syndrome
NPS Pharmaceuticals Has A Billion Plus Blockbuster On Its Hands
Seeking Alpha
Tue, 08/13/13 - 10:55 am
NPS Pharmaceuticals
Gattex
short bowel syndrome
NPS Buys Back Rights to Gattex From Takeda to Spur Sales
Bloomberg
Tue, 03/19/13 - 11:06 am
NPS Pharmaceuticals
Takeda
Gattex
short bowel syndrome
NPS Pharmaceuticals Chief: Why 250k-a-Year Orphan Drug is Worth It
Y Charts
Sun, 02/3/13 - 11:35 am
Gattex
NPS Pharmaceuticals
short bowel syndrome
3 Drug Launches You Need to Know in 2013
Motley Fool
Wed, 01/16/13 - 11:18 am
NPS Pharmaceuticals
Gattex
short bowel syndrome
Iclusig
Ariad
chronic myeloid leukemia
Pfizer
Eliquis
Bristol-Myers Squibb
NPS Gattex Wins Approval for Short-Bowel Syndrome
Bloomberg
Sat, 12/22/12 - 12:19 pm
Gattex
short bowel syndrome
NPS Pharmaceuticals
NPS Pharma Drifts Higher On Potential Orphan Drug Approval
Seeking Alpha
Tue, 12/4/12 - 01:33 pm
NPS Pharmaceuticals
orphan drugs
short bowel syndrome
Gattex
FDA panel votes to support NPS Pharma bowel drug
Yahoo/AP
Wed, 10/17/12 - 11:55 am
NPS Pharmaceuticals
FDA
short bowel syndrome
Gattex
advisory panels
NPS shares halted as FDA panel reviews bowel drug
Yahoo/AP
Tue, 10/16/12 - 11:52 am
NPS Pharmaceuticals
FDA
advisory panels
Gattex
short bowel syndrome
NPS Pharmaceuticals: Buy If There Is A Dip
Seeking Alpha
Sun, 10/14/12 - 11:06 am
NPS Pharmaceuticals
Gattex
short bowel syndrome
2 Biotech Stocks Ready To Flourish In The Wake Of Very Significant FDA News
Seeking Alpha
Sun, 10/14/12 - 11:02 am
Celgene
NPS Pharmaceuticals
lung cancer
Abraxane
Gattex
short bowel syndrome

Pages